Case study: Generating a seed stock from a primary clinical isolate
Scientific challenge
Seed stock from clinical isolate
A clinical-stage biopharmaceutical company required the generation of an RSV seed stock from a primary clinical isolate to support downstream characterisation and preparation for human studies.
Unlike established laboratory-adapted strains, clinical isolates often require extensive optimisation to achieve reliable propagation while maintaining relevant biological characteristics. The project required successful recovery and expansion of virus from clinical material, followed by characterisation, sequencing and generation of a consistent stock suitable for future applications.
The timeline was critical, as the generated virus material was required to support subsequent downstream activities. The workflow therefore required careful coordination between virus propagation, analytical characterisation and external sequencing activities, whilst operating under controlled and clan laboratory conditions for downstream clinical applications.
Virus |
Respiratory Syncytial Virus (RSV) |
Project |
Isolation, expansion and characterisation of RSV clinical isolate for seed stock generation |
Assay |
Virus isolation, propagation, sequencing, infectious virus quantification and stability assessment |
Client |
Clinical-stage biopharmaceutical company |
Stage |
Preparation for human studies |
Services |
Clinical isolate expansion, virus characterisation, sequencing coordination, virus titration, controlled seed stock generation |
Related expertise |
Respiratory viruses, primary clinical isolates, virus propagation optimisation, virus stock generation, quality-controlled workflows |
Key considerations
Unpredictable clinical isolates
Generation of high-quality stocks from primary clinical isolates requires detailed optimisation and close monitoring throughout the process.
Key considerations included:
- optimising propagation parameters including cell conditions, multiplicity of infection (MOI), and culture conditions,
- defining the appropriate number of passages to achieve sufficient viral material while minimising adaptation,
- establishing appropriate freezing conditions and evaluating stock stability,
- maintaining controlled and clean laboratory conditions suitable for downstream clinical applications,
- coordinating external sequencing activities while maintaining project timelines.
Because clinical isolates can behave unpredictably compared with laboratory-adapted viruses, scientific judgement and continuous assessment were essential throughout the process.
Our Approach
Rapid adjustments
VRS combined extensive RSV expertise with a carefully controlled workflow to recover, expand and characterise the clinical isolate.
Following initial recovery, virus propagation conditions were systematically optimised, including selection of appropriate cell conditions, inoculum levels, culture parameters and harvesting strategies.
Throughout the expansion process, viral replication and cytopathic effect were monitored daily by experienced VRS scientists to ensure optimal virus recovery while maintaining biological relevance.
The generated material was subjected to analytical characterisation, including sequencing coordinated through established external partners, and infectious virus quantification.
Close collaboration with the client enabled rapid adjustment of experimental parameters, including passage strategy, culture conditions, formulation of freezing media and evaluation of frozen stock stability.
The complete workflow was performed under controlled conditions designed to provide a high-quality seed stock suitable for downstream development activities.
Outcome
Success allowed downstream studies
VRS successfully generated a characterised RSV clinical isolate seed stock meeting the requirements for subsequent downstream studies.
Through careful optimisation and continuous monitoring, the project achieved the required timeline while maintaining consistency and quality of the generated virus material.
VRS INSIGHT
Clinical isolates require a different approach
Working with primary clinical isolates requires a different approach from working with established laboratory strains, and successful virus expansion depends on understanding viral biology and adapting conditions based on real-time observations.
This project combined hands-on virology expertise with rigorous process control. Through close collaboration with the client and careful optimisation of every stage of the workflow, VRS was able to generate clinically relevant RSV material suitable for advanced downstream studies.
The same workflow was applied to other respiratory viruses for the same client.
Subscribe